Edition:
United States

Akari Therapeutics PLC (AKTX.OQ)

AKTX.OQ on NASDAQ Stock Exchange Capital Market

1.82USD
7 Dec 2018
Change (% chg)

-- (--)
Prev Close
$1.82
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,361
52-wk High
$5.49
52-wk Low
$1.63

Chart for

About

Akari Therapeutics, Plc, formerly Celsus Therapeutics Plc, is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of treatments for a range of rare and orphan autoimmune and inflammatory diseases caused by dysregulation of complement component 5 (C5), including paroxysmal nocturnal... (more)

Overall

Beta: -6.01
Market Cap(Mil.): $27.35
Shares Outstanding(Mil.): 0.16
Dividend: --
Yield (%): --

Financials

  AKTX.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -1.68 -- --
ROI: -256.19 0.60 13.80
ROE: -259.21 -2.18 15.29

Earnings vs. Estimates